ATE431142T1 - Arzneimittel zur behandlung und vermeidung neurogener schmerzen - Google Patents

Arzneimittel zur behandlung und vermeidung neurogener schmerzen

Info

Publication number
ATE431142T1
ATE431142T1 AT01272527T AT01272527T ATE431142T1 AT E431142 T1 ATE431142 T1 AT E431142T1 AT 01272527 T AT01272527 T AT 01272527T AT 01272527 T AT01272527 T AT 01272527T AT E431142 T1 ATE431142 T1 AT E431142T1
Authority
AT
Austria
Prior art keywords
prevention
treatment
medicinal products
neurogenic pain
neurogenic
Prior art date
Application number
AT01272527T
Other languages
German (de)
English (en)
Inventor
Hiroshi Ueda
Munehiro Tomikawa
Original Assignee
Hamilton Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hamilton Pharmaceuticals Inc filed Critical Hamilton Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE431142T1 publication Critical patent/ATE431142T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01272527T 2000-12-28 2001-12-25 Arzneimittel zur behandlung und vermeidung neurogener schmerzen ATE431142T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000400679 2000-12-28
PCT/JP2001/011356 WO2002053153A1 (fr) 2000-12-28 2001-12-25 Medicaments permettant de traiter et de prevenir une douleur neurologique

Publications (1)

Publication Number Publication Date
ATE431142T1 true ATE431142T1 (de) 2009-05-15

Family

ID=18865226

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01272527T ATE431142T1 (de) 2000-12-28 2001-12-25 Arzneimittel zur behandlung und vermeidung neurogener schmerzen

Country Status (11)

Country Link
US (1) US7608636B2 (fr)
EP (1) EP1356812B1 (fr)
JP (1) JPWO2002053153A1 (fr)
KR (1) KR100823668B1 (fr)
CN (1) CN1484527A (fr)
AR (1) AR032066A1 (fr)
AT (1) ATE431142T1 (fr)
CA (1) CA2433039C (fr)
DE (1) DE60138733D1 (fr)
MX (1) MXPA03005889A (fr)
WO (1) WO2002053153A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1611902A4 (fr) * 2003-04-03 2006-04-12 Kyowa Hakko Kogyo Kk Medicament preventif ou curatif pour les douleurs nevropathiques
US7283839B2 (en) 2004-04-14 2007-10-16 Curitel Communications, Inc. Wireless communicating terminal for providing integrated messaging service and method thereof
US20060241144A1 (en) * 2005-04-20 2006-10-26 Albert Cha Method for treating apathy syndrome
ITMI20070770A1 (it) * 2007-04-16 2008-10-17 Brane Discovery S R L Impiego di dimiracetam nel trattamento del dolore cronico
AU2009303834B2 (en) 2008-10-16 2016-08-11 The Johns Hopkins University Methods and compositions for improving cognitive function
ES2664727T3 (es) * 2009-10-22 2018-04-23 University College Dublin National University Of Ireland, Dublin Terapia causal de enfermedades o estados asociados con desmielinización del SNC o del SNP
PL389364A1 (pl) * 2009-10-23 2011-04-26 Uniwersytet Jagielloński Nowe zastosowanie pochodnych 2-pirolidonu
LV14346B (lv) * 2009-11-05 2011-07-20 Grindeks, A/S 2-(4-Fenil-5-metil-2-oksopirolidin-1-il)-acetamīda 4R,5S-enantiomērs ar nootropo aktivitāti
CN102905532A (zh) * 2010-02-09 2013-01-30 约翰斯.霍普金斯大学 用于改善认知功能的方法和组合物
KR101351181B1 (ko) 2010-05-11 2014-01-14 가천대학교 산학협력단 단핵식세포계 세포 내에서 ａｇｅ-알부민의 합성 저해 또는 분비 저해에 의한 세포사 유도 저해 방법
CA2891122C (fr) 2012-11-14 2021-07-20 The Johns Hopkins University Methodes et compositions pour le traitement de la schizophrenie
WO2014144663A1 (fr) 2013-03-15 2014-09-18 The Johns Hopkins University Procédés et compositions pour améliorer la fonction cognitive
WO2014144801A1 (fr) 2013-03-15 2014-09-18 Agenebio Inc. Procédés et compositions pour améliorer la fonction cognitive
EA034167B8 (ru) 2015-05-22 2021-04-27 Эйджинбайо, Инк. Фармацевтические композиции леветирацетама пролонгированного высвобождения
PL244071B1 (pl) * 2019-01-07 2023-11-27 Univ Jagiellonski Pochodne (2,5-dioksopirolidyn-1-ylo)(fenylo)-acetamidu i ich zastosowanie do leczenia chorób o podłożu neurologicznym

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1039113A (en) 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
JPS4219093Y1 (fr) 1965-11-27 1967-11-04
IT1045043B (it) 1975-08-13 1980-04-21 Isf Spa Derivati pirrolidinici
US4118393A (en) * 1977-06-23 1978-10-03 American Cyanamid Company Phenyl azabicyclohexanones
CU21107A3 (es) 1978-02-10 1988-02-01 Hoffmann La Roche Pyrrolidines derivatives
IT1141287B (it) 1979-06-13 1986-10-01 Nattermann A & Cie Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
DE2923975A1 (de) 1979-06-13 1980-12-18 Nattermann A & Cie Pyrrolidinone, verfahren zu deren herstellung und diese enthaltende arzneimittel
CH657527A5 (de) * 1980-02-13 1986-09-15 Ciba Geigy Ag Verwendung von zentralnervoes-wirksamen verbindungen in einem mittel, welches zur verhinderung oder linderung von nebenwirkungen bestimmt ist.
US4431641A (en) 1980-10-17 1984-02-14 Ciba-Geigy Corporation Pharmaceutical compositions having antiepileptic and antineuralgic action
GB8412357D0 (en) 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
JPS625404A (ja) 1985-07-01 1987-01-12 Shinko Electric Co Ltd 信号レベル変換装置
GB8609033D0 (en) * 1986-04-14 1986-05-21 Ucb Sa Pharmaceutical compositions
IT1231477B (it) 1989-07-12 1991-12-07 Sigma Tau Ind Farmaceuti (pirrolidin-2-one-1-il) acetammidi quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
JPH0779442B2 (ja) 1989-07-14 1995-08-23 日本テレビ放送網株式会社 雑音減少回路
JPH04160496A (ja) 1990-10-23 1992-06-03 Sharp Corp 自動販売機の物品搬出機構
US5232700A (en) * 1990-11-14 1993-08-03 The Administrators Of The Tulane Educational Fund Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient
JPH04219093A (ja) 1990-12-19 1992-08-10 Matsushita Electric Ind Co Ltd 磁気記録再生装置
CA2067614C (fr) 1991-05-02 2002-07-30 Eiichi Otomo Agent pour le traitement de la demence
ZA923134B (en) 1991-05-02 1993-01-27 Daiichi Seiyaku Co Agent for improving dementia
JP3388778B2 (ja) 1991-05-02 2003-03-24 第一製薬株式会社 脳血管性痴呆改善剤
FI102748B (fi) 1992-06-19 1999-02-15 Daiichi Seiyaku Co Menetelmä N-(2,6-dialkyylifenyyli)-2-(2-okso-1-pyrrolidinyyli)asetamid ijohdannaisen valmistamiseksi
GB9505692D0 (en) * 1995-03-21 1995-05-10 Glaxo Group Ltd Chemical compounds
US5885976A (en) * 1995-05-08 1999-03-23 Sandyk; Reuven Methods useful for the treatment of neurological and mental disorders related to deficient serotonin neurotransmission and impaired pineal melatonin functions
CN1080805C (zh) * 1995-08-04 2002-03-13 海德罗－弗罗控股公司 活塞阀
US6107330A (en) 1995-08-07 2000-08-22 Daiichi Pharmaceutical Co., Ltd. Inhibitor for narcotic analgesic dependence/resistance acquisition
US5551846A (en) 1995-12-01 1996-09-03 Ford Motor Company Scroll compressor capacity control valve
WO1998014213A1 (fr) 1996-10-01 1998-04-09 Daiichi Pharmaceutical Co., Ltd. Stabilisateur de la membrane mitochondriale
ATE266401T1 (de) 1997-07-15 2004-05-15 Daiichi Seiyaku Co Nefiracetam zur prophylaxe und behandlung von propofol verursachtem gedächtnisschwund
AR020115A1 (es) 1998-08-06 2002-04-10 Daiichi Seiyaku Co Agente terapeutico o preventivo para epilepsias rebeldes y uso del compuesto para la produccion de los mismos
US20040077709A1 (en) * 1999-05-31 2004-04-22 Daiichi Pharmaceutical Co., Ltd. Neuronal death inhibitors
CN1368882A (zh) 1999-05-31 2002-09-11 第一制药株式会社 神经元死亡抑制剂
US6349442B1 (en) * 1999-06-23 2002-02-26 Advanced Prosthetic Technologies, Inc. Brush tip for a motorized toothbrush
NZ518901A (en) 1999-12-01 2004-08-27 Ucb S A levetiracetam alone or in combination with a compound inducing neural inhibition mediated by the GABA receptors for treatment of chronic pain, bipolar disorder, mania and migraine
US6423739B1 (en) * 2000-02-23 2002-07-23 Daiichi Pharmaceutical Co., Ltd. Method for aiding cerebral recovery following neurodegeneration

Also Published As

Publication number Publication date
US20040063776A1 (en) 2004-04-01
KR100823668B1 (ko) 2008-04-21
DE60138733D1 (de) 2009-06-25
CN1484527A (zh) 2004-03-24
CA2433039C (fr) 2010-06-08
EP1356812A4 (fr) 2006-04-12
EP1356812B1 (fr) 2009-05-13
EP1356812A1 (fr) 2003-10-29
AR032066A1 (es) 2003-10-22
WO2002053153A1 (fr) 2002-07-11
KR20040025882A (ko) 2004-03-26
US7608636B2 (en) 2009-10-27
CA2433039A1 (fr) 2002-07-11
JPWO2002053153A1 (ja) 2004-04-30
MXPA03005889A (es) 2005-02-14

Similar Documents

Publication Publication Date Title
ATE289512T1 (de) Arzneimittel zur behandlung der mucositis, stomatitis und des behcetschen syndroms
ATE434444T1 (de) Vorbeugung und behandlung von amyloidogenischen krankheiten
DE69802260D1 (de) Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
DE60108080D1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
NO20014046D0 (no) Gabapentinderivater for forhindring og behandling av visceral smerte
DE60109589D1 (de) Pharmazeutische zusammensetzung zur behandlung von akutem schmerz, chronischem schmerz und/oder neuropathischem schmerz und migräne
HUP0302476A3 (en) Use of acetylcholinesterase inhibitors and gabaainverse agonists for the treatment of cognitive disorders and for preparation of pharmaceutical compositins
DE69830728D1 (de) Arzneimittel zur behandlung von häufigem wasserlassen und harninkontinenz
EP1399171A4 (fr) Composes d'herbes medicinales destines a la prevention et au traitement du diabete
ATE431142T1 (de) Arzneimittel zur behandlung und vermeidung neurogener schmerzen
DE69806801T2 (de) Galenische präparation zur prävention und behandlung von hepatokarzinomen
IL127943A (en) Pharmaceutical and cosmetic compositions for the treatment of skin disorders
DE50010284D1 (de) Arzneimittel zur behandlung von bluthochdruck
DE19580261D2 (de) Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktion
ATE416779T1 (de) Arzneimittel mit anemonin als aktivum zur behandlung von aseptischer inflammation
DE60132851D1 (de) Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension
EE200200271A (et) Ravimkombinatsioonid ning nende kasutamine
DE60027209D1 (de) Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
DE60139783D1 (de) Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
DE69939075D1 (de) Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
DE60107900D1 (de) Pharmazeutische Zusammensetzung und Nahrungsmittel zur Behandlung von Gehirnödem
ATE314064T1 (de) L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit
DE60036723D1 (de) Mesoprogestine zur behandlung und vorbeugung von hormonabhängigen gutartigen gynekologischen störungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties